The Prostatitis Foundation

International Prostatitis Collaborative Network 3rd Annual Meeting Agenda
Back to ICPN3 Home

 

October 23-25th, 2000
Sheraton Crystal City
Arlington, Virginia
Prostatitis Workshop

Monday, October 23
7:30 - 8:30 am - Registration
8:30 - 8:45 am - Welcome, Purpose and Goals of Meeting : Dr. Leroy Nyberg, NIH
   (running time 1 min. 9 sec., 2 mb)and
Dr. Curtis Nickel, Queens University, Kingston Canada

Session I
Pathological Findings associated with Chronic Prostatitis
Moderated and introduced by Dr. John Krieger, University of Washington.
8:45 - 9:15 - Expert Presentation, Dr. Larry True, University of Washington .
9:15 - 9:45 - Questions and Answers, Drs. True and Krieger

Session II
Immunology and Chronic Prostatitis
9:45 - 10:45 Dr Richard Alexander, University of Maryland Baltimore
    Part one: introduction to prostate immunology
    Part two: main body of presentation
    Part three: conclusion
    Part four: question and answer session

Session III
Infertility and Chronic Prostatitis
11:00 - 11:30 - Expert Presentation
1:30 - 12:00 - Questions and Answers

Session IV
Phytotherapy (herbals) and Chronic Prostatitis
1:00 - 2:00 - Expert Presentation and Questions and Answers

3:00 - 6:00 pm Poster Session and Abstract Presentations

Abstract Presentations will be strictly limited to 5 minutes and will be presented in the order indicated on this agenda

R. Batstone
Could a pelvic pain score be useful in an assessment of men with chronic pelvic pain?
Diane Hetrick
Pelvic Muscle Evaluation in Men With Chronic Pelvic Pain and Controls
W.W. Hochreiter
Comparison of Urodynamic Findings in Patients with Chronic Pelvic Pain Syndrome IIIA and IIIB
A. Mehik
One Year Experience of Using The National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) for Diagnosis and Survey of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
L.D. Rabon
PSA Elevation With Chronic Pelvic Pain Syndrome - A Case Study
R. Batstone
The Stamey localisation procedure is painful
N. F. Wasserman
High PSA Prostatic Inflammation
10 Minute Discussions

Antibiotic Therapy 3:45-4:15
J. Dimitrakov
A Prospective, Randomized, double-blind, Placebo-Controlled Study of Antibiotics for the Treatment of Category IIIB Chronic Pelvic Pain Syndrome in Men
Bradley R. Hennenfent
Symptom Improvement and TRUS-Documented Reduction of Prostate Size after Repetitive Prostatic Massage and Antimicrobial Therapy
H. Ljungn³r
Transrectal thermotherapy of chronical prostatitis.
J. Nickel
ROFECOXIB in the Treatment of Chronic Nonbacterial Prostatitis: A Phase II Randomized Placebo Controlled Study
10 Minute Discussions

Other Therapies 4:15-4:55
B. Gushchin
Epidemiological data on the prevalent diagnostic and treatment procedures for chronic prostatitis in the ambulatory care setting
J. L. NGUYEN QUI
Prostatitis in France,a very common disease- A 15 years experience.
J. W. Polacheck
A Beneficial Effect of Prostate Massage for Patients with Chronic Prostatits: The Expression of Intraglandular Prostatic Inflamatory Aggregates
J.M. Potts
Preliminary Results of Pelvic Floor Physical Therapy in the Treatment of Select Patients Diagnosed with Chronic Pelvic Pain Syndrome: Category III Prostatitis Survey Patients Reported Responses to Therapies.
D. Wise
Details of Treatment of Prostatitis Understood as a Tension Disorder: Intrapelvic Myofascial Release and Progressive Relaxation of the Pelvic Floor
F. Guercini
Ultrasound-Guided Infiltration in Chronic Prostatitis
10 Minute Discussions

Basic Science 4:55-5:25
R. Batstone
The results of an auto-immune screen in patients with types IIIa and IIIb prostatitisJ. Dimitrakov
Single Nucleotide Polymorphism Studies in Patients with CPPS: Preliminary Results
P. Fugazzotto
Application of Universal Academic Principles to Diagnosis and Management of Pelvic Disorders (PD); Prostatitis in Particular
S. Mazzoli
Chlamydia pneumoniae as an impacting emerging pathogen in prostate pathologies
10 Minute Discussions

Pathophysiology 5:25-6:10
Stanley J. Antolak, Jr.
Category III Prostatitis: Changing the Paradigm: The Role of Pudendal Nerve Entrapment
J. Dimitrakov
Comparison of a Mollicute-Specific PCR, a Ureaplasma-Specific PCR, and a RAPD Protocol for Detection of Ureaplasma Urealyticum in Men with Chronic Prostatitis
J. W. Polacheck
A Histopathological Framework for Prostatitis
D.E. Riley
Strategies for Identifying Prostatitis"Predisposing Genetic Loci
D. A. Shoskes
Correlation of b-endorphin and PGE2 Levels in Prostatic Fluid of Men with Chronic Prostatitis/CPPS
R. Trammell
Identification of high-titer autoantibodies to prostate-associated antigens in some patients with chronic abacterial prostatitis.
A. Doble
The Immunopathology of Chronic Pelvic Pain Syndrome-Type IIIa
10 Minute Discussions

6:10pm-7:00pm Poster viewing
7:00 pm Adjourned

Tuesday - October 24
8:30 - 9:00 am The Treatment Of Chronic Prostatitis - Evidence based medicine --Dr. Mary McNaughton-Collins on how much (or little) we really know from scientific research about how to treat chronic prostatitis.
9:00 - 9:30 am The Chronic Prostatitis Collaborative Network
9:30 - 11:30 am Clinical/Patient Panels

Diagnosis
Treatment
Refractory Prostatitis
"What we expect" - a patient panel
11:30 - 12:30 pm International Collaborative Studies

The Prostatitis Foundation hosted patient-oriented presentations Tuesday afternoon and Wednesday morning.

 

.........................................................................................
We're sorry you are having to learn about prostatitis, but we're glad you came here, because we think we can help. Please be advised that the Prostatitis Foundation does
not warrant, support, sponsor, endorse, recommend or accept responsibility for any health care provider or any treatment or protocol performed by any heath care provider.

© The Prostatitis Foundation
.........................................................................................

 
Add To Site Contact Home